PE799A1 - Composicion cosmetica que contiene un antagonista de los receptores del neuropeptido y - Google Patents
Composicion cosmetica que contiene un antagonista de los receptores del neuropeptido yInfo
- Publication number
- PE799A1 PE799A1 PE1997000944A PE00094497A PE799A1 PE 799 A1 PE799 A1 PE 799A1 PE 1997000944 A PE1997000944 A PE 1997000944A PE 00094497 A PE00094497 A PE 00094497A PE 799 A1 PE799 A1 PE 799A1
- Authority
- PE
- Peru
- Prior art keywords
- antagonist
- npy
- composition containing
- cosmetic composition
- component
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P17/00—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
- C12P17/16—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms containing two or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/742—Spore-forming bacteria, e.g. Bacillus coagulans, Bacillus subtilis, clostridium or Lactobacillus sporogenes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
- A61K8/494—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with more than one nitrogen as the only hetero atom
- A61K8/4953—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with more than one nitrogen as the only hetero atom containing pyrimidine ring derivatives, e.g. minoxidil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9728—Fungi, e.g. yeasts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9771—Ginkgophyta, e.g. Ginkgoaceae [Ginkgo family]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/99—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from microorganisms other than algae or fungi, e.g. protozoa or bacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/06—Preparations for care of the skin for countering cellulitis
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/20—Bacteria; Culture media therefor
- C12N1/205—Bacterial isolates
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P11/00—Preparation of sulfur-containing organic compounds
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P17/00—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P7/00—Preparation of oxygen-containing organic compounds
- C12P7/24—Preparation of oxygen-containing organic compounds containing a carbonyl group
- C12P7/26—Ketones
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P7/00—Preparation of oxygen-containing organic compounds
- C12P7/62—Carboxylic acid esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/70—Biological properties of the composition as a whole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
- A61K2800/85—Products or compounds obtained by fermentation, e.g. yoghurt, beer, wine
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09K—MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
- C09K2323/00—Functional layers of liquid crystal optical display excluding electroactive liquid crystal layer characterised by chemical composition
- C09K2323/06—Substrate layer characterised by chemical composition
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
- C12R2001/00—Microorganisms ; Processes using microorganisms
- C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
- C12R2001/07—Bacillus
- C12R2001/10—Bacillus licheniformis
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
- C12R2001/00—Microorganisms ; Processes using microorganisms
- C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
- C12R2001/465—Streptomyces
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T428/00—Stock material or miscellaneous articles
- Y10T428/29—Coated or structually defined flake, particle, cell, strand, strand portion, rod, filament, macroscopic fiber or mass thereof
- Y10T428/2982—Particulate matter [e.g., sphere, flake, etc.]
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Genetics & Genomics (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Mycology (AREA)
- Birds (AREA)
- Medicinal Chemistry (AREA)
- Tropical Medicine & Parasitology (AREA)
- Dermatology (AREA)
- Pharmacology & Pharmacy (AREA)
- Molecular Biology (AREA)
- Botany (AREA)
- Virology (AREA)
- Biomedical Technology (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Cosmetics (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
SE REFIERE A UNA COMPOSICION COSMETICA QUE CONTIENE AL MENOS UN COMPONENTE ANTAGONISTA DE LOS RECEPTORES DEL NEUROPEPTIDO "Y" (NPY) MEZCLADO CON UN EXCIPIENTE PARA PREPARACIONES COSMETICAS, DONDE EL COMPONENTE NPY-ANTAGONISTA SE ELIGE ENTRE UN COMPUESTO DE SINTESIS NO PEPTIDICO, UN PEPTIDO, UN EXTRACTO DE CELULAS EN TEJIDOS DE ORIGEN ANIMAL O VEGETAL Y UN PRODUCTO PROVENIENTE DE LA FERMENTACION DE UN MICROORGANISMO ELEGIDO ENTRE BACTERIAS Y HONGOS. SE REFIERE TAMBIEN A UN PROCEDIMIENTO DE PREPARACION DE UN PRODUCTO NPY-ANTAGONISTA SOBRE UN MEDIO DE FERMENTACION Y EN CONDICIONES CLASICAS HASTA LA OBTENCION, EN EL MOSTO DE FERMENTACION, DE UNA ACTIVIDAD ANTAGONISTA DE LOS RECEPTORES NPY Y SE RECUPERA EL SOBRENADANTE PURIFICANDOLO POR CROMATOGRAFIA DE PERMEACION SOBRE GEL O POR CROMATOGRAFIA DE ABSORCION Y SE RECUPERA EL PRODUCTO PURIFICADO. DICHO NPY-ANTAGONISTA TIENE USO PARA LA FABRICACION DE COMPOSICIONES COSMETICAS DESTINADAS A REGULAR LA LIPOLISIS/LIPOGENESIS A NIVEL DE LA PIEL, EN ESPECIAL CON FINES ADELGAZANTES, REGULADORES DE LA SEBORREA Y COMO ADYUVANTE DURANTE O DESPUES DEL TRATAMIENTO DEL ACNE
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR9612916A FR2754709B1 (fr) | 1996-10-23 | 1996-10-23 | Composition cosmetique contenant un antagoniste des recepteurs du neuropeptide gamma et alpha 2 antagonistes susceptibles d'etre incorpores dans une telle composition |
Publications (1)
Publication Number | Publication Date |
---|---|
PE799A1 true PE799A1 (es) | 1999-04-08 |
Family
ID=9496938
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PE1997000944A PE799A1 (es) | 1996-10-23 | 1997-10-23 | Composicion cosmetica que contiene un antagonista de los receptores del neuropeptido y |
Country Status (23)
Country | Link |
---|---|
US (3) | US5827853A (es) |
EP (3) | EP1093803B1 (es) |
JP (1) | JP3411463B2 (es) |
KR (1) | KR100240143B1 (es) |
CN (1) | CN1214780C (es) |
AR (1) | AR005583A1 (es) |
AT (3) | ATE408396T1 (es) |
AU (1) | AU705046B2 (es) |
BR (1) | BR9700835A (es) |
CA (1) | CA2196096C (es) |
CO (1) | CO4780017A1 (es) |
DE (3) | DE69739002D1 (es) |
ES (3) | ES2191154T3 (es) |
FR (1) | FR2754709B1 (es) |
HK (1) | HK1008981A1 (es) |
HU (1) | HU222663B1 (es) |
IL (1) | IL120092A (es) |
MX (1) | MX9700822A (es) |
MY (1) | MY117993A (es) |
PE (1) | PE799A1 (es) |
PT (2) | PT1093803E (es) |
SI (3) | SI1132463T1 (es) |
TW (1) | TW434024B (es) |
Families Citing this family (55)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2728793A1 (fr) * | 1994-12-28 | 1996-07-05 | Oreal | Utilisation d'un antagoniste d'histamine, d'un antagoniste d'interleukine 1 et/ou d'un antagoniste de tnf-alpha dans une composition cosmetique, pharmaceutique ou dermatologique et composition obtenue |
US8466109B2 (en) * | 1998-10-05 | 2013-06-18 | Laboratoires Expanscience | Cosmetic method for preventing and/or treating skin stretchmarks, and use in dermatology |
FR2787712B1 (fr) * | 1998-12-24 | 2002-08-30 | Sanofi Sa | Composition cosmetique pulverisable et matrice utilisable dans cette composition pour une administration dermique |
US6375948B1 (en) * | 1999-07-12 | 2002-04-23 | Kao Corporation | Treating method for suppressing hair growth |
FR2800610B1 (fr) * | 1999-11-05 | 2001-12-28 | Sanofi Synthelabo | Composition cosmetique amincissante contenant une substance inducteur de la production d'il-6 |
WO2001053477A1 (en) * | 2000-01-20 | 2001-07-26 | Baylor College Of Medicine | Methods and compositions for control of bone formation via modulation of neuropeptide y activity |
EP1337257A4 (en) * | 2000-10-03 | 2004-04-07 | Univ California | USE OF NEUROPEPTIDE Y ANTAGONISTS IN THE TREATMENT OF ALCOHOLISM |
US7069026B2 (en) * | 2001-06-28 | 2006-06-27 | Nokia Corporation | Geographic area assisted system selection for mobile stations |
WO2003009854A1 (en) * | 2001-07-20 | 2003-02-06 | Lonza Ag | Lipid lowering composition comprising carnitine and phytosterol |
IL162269A0 (en) | 2001-12-05 | 2005-11-20 | Baylor College Medicine | Methods and compositions for control of bone formation via modulation of sympathetic tone |
US20030166732A1 (en) * | 2002-02-27 | 2003-09-04 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Ambroxol for the treatment of painful conditions in the mouth and pharyngeal cavity |
FR2853541B1 (fr) * | 2003-04-09 | 2008-07-04 | Oreal | Composition cosmetique stable contenant un glyceride d'acides gras, un alcool et un emulsionnant silicone particulier |
EP1620091B1 (en) | 2003-05-05 | 2010-03-31 | Probiodrug AG | Inhibitors of glutaminyl cyclase |
DE10340417C5 (de) * | 2003-09-02 | 2011-05-05 | Sebapharma Gmbh & Co. Kg | Kosmetische oder dermatologische Zubereitung mit Phytosterolen in Form einer W/O-Emulsion |
NZ546887A (en) | 2003-11-03 | 2009-04-30 | Probiodrug Ag | Combinations useful for the treatment of neuronal disorders |
JP4996926B2 (ja) | 2004-02-05 | 2012-08-08 | プロビオドルグ エージー | グルタミニルシクラーゼの新規の阻害剤 |
US20060127468A1 (en) | 2004-05-19 | 2006-06-15 | Kolodney Michael S | Methods and related compositions for reduction of fat and skin tightening |
BRPI0512189B1 (pt) * | 2004-06-15 | 2018-02-06 | The Boots Company Plc | Hair care compositions and methods |
FR2871688B1 (fr) | 2004-06-16 | 2008-05-16 | Oreal | Procede pour favoriser la penetration d'un actif et composition permettant sa mise en oeuvre |
US20090213731A1 (en) * | 2005-04-15 | 2009-08-27 | Regenertech Pty Limited | Use of neuropeptide y (npy) and agonists and antagonists thereof for tissue regeneration |
EP1888101B1 (en) * | 2005-06-06 | 2012-03-21 | Georgetown University | Compositions and methods for lipo modeling |
JP4960960B2 (ja) * | 2005-06-24 | 2012-06-27 | マルコ ブランデスティーニ | 衝撃による硬度測定装置 |
FR2895239B1 (fr) * | 2005-12-22 | 2008-05-30 | Oreal | Utilisation d'un antagoniste du neuropeptide y pour le soin des levres endommagees ou sensibles |
EP2089383B1 (en) | 2006-11-09 | 2015-09-16 | Probiodrug AG | 3-hydr0xy-1,5-dihydr0-pyrr0l-2-one derivatives as inhibitors of glutaminyl cyclase for the treatment of ulcer, cancer and other diseases |
ATE554085T1 (de) | 2006-11-30 | 2012-05-15 | Probiodrug Ag | Neue inhibitoren von glutaminylcyclase |
EP1970051A1 (en) * | 2007-03-14 | 2008-09-17 | Merz Pharma GmbH & Co.KGaA | Use of an aqueous micro-emulsion for the preparation of a formulation for the treatment of adipose diseases |
MX2009009234A (es) | 2007-03-01 | 2009-12-01 | Probiodrug Ag | Uso nuevo de inhibidores de ciclasa de glutaminilo. |
WO2008128985A1 (en) | 2007-04-18 | 2008-10-30 | Probiodrug Ag | Thiourea derivatives as glutaminyl cyclase inhibitors |
GB0719545D0 (en) * | 2007-10-08 | 2007-11-14 | Barry Callebaut Ag | Novel use of cocoa extract |
GB0719542D0 (en) * | 2007-10-08 | 2007-11-14 | Barry Callebaut Ag | Use of cocoa extract |
GB0719544D0 (en) * | 2007-10-08 | 2007-11-14 | Barry Callebaut Ag | Cocoa extract and use thereof |
US20080318870A1 (en) | 2007-06-19 | 2008-12-25 | Kythera Biopharmaceuticals, Inc. | Synthetic bile acid compositions and methods |
US8242294B2 (en) | 2007-06-19 | 2012-08-14 | Kythera Biopharmaceuticals, Inc. | Synthetic bile acid compositions and methods |
AU2008265721B2 (en) * | 2007-06-19 | 2014-03-20 | Kythera Biopharmaceuticals, Inc. | Synthetic bile acid composition, method, and preparation |
JOP20180077A1 (ar) * | 2007-06-19 | 2019-01-30 | Kythera Biopharmaceuticals Inc | تركيبات وطرق لحمض صفراوي تخليقي |
US20090263518A1 (en) | 2008-04-17 | 2009-10-22 | Barry Callebaut Ag | Composition and Uses Thereof |
US8101593B2 (en) | 2009-03-03 | 2012-01-24 | Kythera Biopharmaceuticals, Inc. | Formulations of deoxycholic acid and salts thereof |
US20100233301A1 (en) * | 2009-03-11 | 2010-09-16 | Jing Cheng | Topical compositions comprising fermented extracts of traditional chinese medicinal (tcm) ingredients, and methods of making and using same |
KR101755737B1 (ko) | 2009-09-11 | 2017-07-07 | 프로비오드룩 아게 | 글루타미닐 사이클라제의 억제제로서 헤테로사이클릭 유도체 |
FR2953716B1 (fr) | 2009-12-16 | 2015-03-27 | Oreal | Kit de formulation d'un produit cosmetique |
US9181233B2 (en) | 2010-03-03 | 2015-11-10 | Probiodrug Ag | Inhibitors of glutaminyl cyclase |
CA2789440C (en) | 2010-03-10 | 2020-03-24 | Probiodrug Ag | Heterocyclic inhibitors of glutaminyl cyclase (qc, ec 2.3.2.5) |
JP5945532B2 (ja) | 2010-04-21 | 2016-07-05 | プロビオドルグ エージー | グルタミニルシクラーゼの阻害剤としてのベンゾイミダゾール誘導体 |
CA2783017C (en) | 2010-08-12 | 2018-05-15 | Kythera Biopharmaceuticals, Inc. | Synthetic bile acid compositions and methods |
FR2967573B1 (fr) | 2010-11-23 | 2012-11-09 | Rhodia Poliamida E Especialidades Ltda | Kit cosmetique et utilisation pour ameliorer l'aspect de la peau |
MX363465B (es) | 2011-02-18 | 2019-03-25 | Kythera Biopharmaceuticals Inc | Tratamiento de la grasa submental. |
ES2570167T3 (es) | 2011-03-16 | 2016-05-17 | Probiodrug Ag | Derivados de benzimidazol como inhibidores de glutaminil ciclasa |
US8653058B2 (en) | 2011-04-05 | 2014-02-18 | Kythera Biopharmaceuticals, Inc. | Compositions comprising deoxycholic acid and salts thereof suitable for use in treating fat deposits |
NZ620040A (en) | 2011-08-23 | 2016-06-24 | Kythera Biopharmaceuticals Inc | Formulations of deoxycholic acid and salts thereof |
EP2735310B1 (en) | 2011-08-23 | 2017-10-11 | Kythera Biopharmaceuticals, Inc. | Formulations of deoxycholic acid and salts thereof |
EP2773431B1 (en) * | 2011-10-25 | 2019-03-20 | Arch Personal Care Products, L.P. | Composition containing an extract of a sequential or simultaneous fermentation |
JP6300641B2 (ja) * | 2014-05-30 | 2018-03-28 | ワミレスコスメティックス株式会社 | 皮膚バリア機能改善効果を有する放線菌培養物 |
JP2018532806A (ja) | 2015-11-04 | 2018-11-08 | キセラ バイオファーマシューティカルズ インコーポレイテッド | デオキシコール酸およびその塩による蓄積脂肪の処置方法 |
JP6938860B2 (ja) * | 2016-06-13 | 2021-09-22 | 株式会社リコー | 形状支持用液体、及び立体造形物の製造方法 |
ES2812698T3 (es) | 2017-09-29 | 2021-03-18 | Probiodrug Ag | Inhibidores de glutaminil ciclasa |
Family Cites Families (43)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2979511A (en) | 1959-03-25 | 1961-04-11 | Olin Mathieson | Certain 1, 4-benzodioxanyl imidazolines and corresponding pyrimidines and process |
DE2603407A1 (de) | 1976-01-29 | 1977-08-04 | Wmf Wuerttemberg Metallwaren | Wasserkessel |
IL56369A (en) | 1978-01-20 | 1984-05-31 | Erba Farmitalia | Alpha-phenoxybenzyl propanolamine derivatives,their preparation and pharmaceutical compositions comprising them |
US4337260A (en) | 1981-09-10 | 1982-06-29 | Yoshitomi Pharmaceutical Industries, Ltd. | Imidazopyridine-spiro-piperidine compounds |
GB2138023A (en) * | 1983-03-29 | 1984-10-17 | Mitsui Toatsu Chemicals | Bacillus licheniformis used in animal feeds |
JPS59192086A (ja) * | 1983-04-15 | 1984-10-31 | Mitsui Toatsu Chem Inc | バチルス・リケニホルミスmn001 |
DE3410033A1 (de) | 1984-03-19 | 1985-09-26 | Alfred Teves Gmbh, 6000 Frankfurt | Vorrichtung zur hydraulischen unterstuetzung der lenkkraft |
US5128332A (en) * | 1984-10-23 | 1992-07-07 | Perstorp Ab | Method of treating cardiovascular diseases using inositoltrisphosphate |
GB2167408B (en) | 1984-11-23 | 1988-05-25 | Farmos Oy | Substituted imidazole derivatives and their preparation and use |
JPS61155317A (ja) * | 1984-12-28 | 1986-07-15 | Lion Corp | 口腔用組成物 |
DE3545986A1 (de) * | 1985-12-23 | 1987-06-25 | Franz Sauter | Elektronisch gesteuertes musikinstrument |
DE3790919T1 (de) * | 1987-02-24 | 1989-03-23 | Inst Mikrobiologii Virusologii | Arzneimittel zur prophylaxe und behandlung von gastrointerfinalen erkrankungen des landwirtschaftsviehs |
DE3811193A1 (de) | 1988-04-01 | 1989-10-19 | Boehringer Ingelheim Kg | Neue peptide, verfahren zu ihrer herstellung und diese peptide enthaltende pharmazeutische zusammensetzungen |
US5328899A (en) | 1988-07-15 | 1994-07-12 | The Salk Institute For Biological Studies | NPY peptide analogs |
EP0356399A3 (en) * | 1988-08-26 | 1991-03-20 | Sandoz Ag | Substituted 4-azatricyclo (22.3.1.04.9) octacos-18-ene derivatives, their preparation and pharmaceutical compositions containing them |
ZA896374B (en) | 1988-08-26 | 1990-05-30 | Merrell Dow Pharma | Neuropeptide y antagonists |
US5116605A (en) * | 1989-03-09 | 1992-05-26 | Alt John P | Composition and skin treatment method therewith for mitigating acne and male-pattern baldness |
ATE109979T1 (de) | 1990-03-30 | 1994-09-15 | Heumann Pharma Gmbh & Co | Verwendung von guanidinderivaten zur herstellung eines arzneimittels mit npy-antagonistischer wirkung. |
SE9002278L (sv) | 1990-06-28 | 1991-12-29 | Perstorp Ab | Anvaendning av inositoltrisfosfat foer framstaellning av ett laekemedel |
SE467340B (sv) * | 1990-07-04 | 1992-07-06 | Perstorp Ab | Anvaendning av inositolmonofosfat foer framstaellning av ett laekemedel effektivt som en neuropeptid y-(npy-)antagonist |
FR2669537B1 (fr) * | 1990-11-28 | 1993-02-19 | Oreal | Composition amincissante a base d'alpha-2-bloqueurs. |
TW263508B (es) | 1991-02-12 | 1995-11-21 | Pfizer | |
WO1993012139A1 (en) | 1991-12-19 | 1993-06-24 | Garvan Institute Of Medical Research | A novel molecule which inhibits neuropeptide tyrosine biological function |
GB9213215D0 (en) | 1992-06-20 | 1992-08-05 | Wellcome Found | Peptides |
DE4326465A1 (de) | 1993-01-20 | 1995-02-09 | Thomae Gmbh Dr K | Aminosäurederivate, diese Verbindungen enthaltende Arzneimittel und Verfahren zu ihrer Herstellung |
FR2701480B1 (fr) | 1993-02-15 | 1995-05-24 | Sanofi Elf | Composés à groupe sulfamoyle et amidino, leur procédé de préparation et les compositions pharmaceutiques les contenant. |
DE4311756A1 (de) | 1993-04-08 | 1994-10-13 | Thomae Gmbh Dr K | Modifizierte Peptide, diese Verbindungen enthaltende Arzneimittel und Verfahren zu ihrer Herstellung |
EP0707490A1 (en) | 1993-06-18 | 1996-04-24 | University Of Cincinnati | Neuropeptide y antagonists and agonists |
JPH07258068A (ja) * | 1994-03-18 | 1995-10-09 | Kao Corp | 浴用剤組成物 |
JP3447809B2 (ja) * | 1994-07-12 | 2003-09-16 | 花王株式会社 | 浴用剤 |
DE69420411T2 (de) * | 1994-10-06 | 2000-04-06 | Susumu Hibino | Bakterielle Mittel zur Landwirtschaftlichen Verwendung |
IL115613A0 (en) | 1994-10-20 | 1996-01-19 | Lilly Co Eli | Bicyclic neuropeptide y receptor antagonists |
US6562862B1 (en) | 1994-10-20 | 2003-05-13 | Eli Lilly And Company | Methods of inhibiting physiological conditions associated with an excess of neuropeptide Y |
BR9509610A (pt) * | 1994-11-07 | 1997-10-28 | Pfizer | Ligandos específicos de neuropeptideo Y1 |
FR2728793A1 (fr) * | 1994-12-28 | 1996-07-05 | Oreal | Utilisation d'un antagoniste d'histamine, d'un antagoniste d'interleukine 1 et/ou d'un antagoniste de tnf-alpha dans une composition cosmetique, pharmaceutique ou dermatologique et composition obtenue |
US5621079A (en) * | 1995-02-03 | 1997-04-15 | Merck & Co., Inc. | Neuropeptide Y receptor |
US5536499A (en) * | 1995-02-24 | 1996-07-16 | Chesebrough-Pond's Usa Co., Division Of Conopco, Inc. | Cosmetic compositions for reducing or preventing signs of cellulite |
US5552411A (en) | 1995-05-26 | 1996-09-03 | Warner-Lambert Company | Sulfonylquinolines as central nervous system and cardiovascular agents |
US5554621A (en) | 1995-06-07 | 1996-09-10 | Bristol-Myers Squibb Company | Dihydropyridine NPY antagonists: nitrogen heterocyclic derivatives |
US5552148A (en) * | 1995-06-07 | 1996-09-03 | Chesebrough-Pond's Usa Co., Division Of Conopco, Inc. | Petroleum jelly with inositol phosphates |
US5646151A (en) * | 1996-03-08 | 1997-07-08 | Adolor Corporation | Kappa agonist compounds and pharmaceutical formulations thereof |
FR2787712B1 (fr) * | 1998-12-24 | 2002-08-30 | Sanofi Sa | Composition cosmetique pulverisable et matrice utilisable dans cette composition pour une administration dermique |
FR2788434B1 (fr) * | 1999-01-15 | 2001-05-11 | Oreal | Utilisation d'au moins un extrait d'au moins une bacterie filamenteuse non photosynthetique en tant qu'agent amincissant |
-
1996
- 1996-10-23 FR FR9612916A patent/FR2754709B1/fr not_active Expired - Fee Related
-
1997
- 1997-01-23 SI SI9730784T patent/SI1132463T1/sl unknown
- 1997-01-23 DE DE69739002T patent/DE69739002D1/de not_active Expired - Lifetime
- 1997-01-23 ES ES97400161T patent/ES2191154T3/es not_active Expired - Lifetime
- 1997-01-23 AT AT01100818T patent/ATE408396T1/de active
- 1997-01-23 PT PT01100818T patent/PT1093803E/pt unknown
- 1997-01-23 AT AT97400161T patent/ATE230974T1/de active
- 1997-01-23 SI SI9730783T patent/SI1093803T1/sl unknown
- 1997-01-23 AT AT01100820T patent/ATE412399T1/de active
- 1997-01-23 ES ES01100820T patent/ES2316403T3/es not_active Expired - Lifetime
- 1997-01-23 EP EP01100818A patent/EP1093803B1/fr not_active Expired - Lifetime
- 1997-01-23 EP EP97400161A patent/EP0838217B1/fr not_active Expired - Lifetime
- 1997-01-23 SI SI9730475T patent/SI0838217T1/xx unknown
- 1997-01-23 PT PT01100820T patent/PT1132463E/pt unknown
- 1997-01-23 DE DE69718409T patent/DE69718409T2/de not_active Expired - Lifetime
- 1997-01-23 DE DE69739079T patent/DE69739079D1/de not_active Expired - Lifetime
- 1997-01-23 EP EP01100820A patent/EP1132463B1/fr not_active Expired - Lifetime
- 1997-01-23 ES ES01100818T patent/ES2313914T3/es not_active Expired - Lifetime
- 1997-01-27 US US08/790,761 patent/US5827853A/en not_active Expired - Lifetime
- 1997-01-27 CA CA002196096A patent/CA2196096C/en not_active Expired - Fee Related
- 1997-01-28 IL IL12009297A patent/IL120092A/en not_active IP Right Cessation
- 1997-01-29 AR ARP970100344A patent/AR005583A1/es active IP Right Grant
- 1997-01-31 MX MX9700822A patent/MX9700822A/es unknown
- 1997-01-31 BR BR9700835A patent/BR9700835A/pt not_active Application Discontinuation
- 1997-02-04 AU AU12515/97A patent/AU705046B2/en not_active Ceased
- 1997-02-04 MY MYPI97000411A patent/MY117993A/en unknown
- 1997-02-10 HU HU9700410A patent/HU222663B1/hu not_active IP Right Cessation
- 1997-02-13 JP JP02895097A patent/JP3411463B2/ja not_active Expired - Fee Related
- 1997-03-14 CN CNB971030375A patent/CN1214780C/zh not_active Expired - Fee Related
- 1997-03-19 KR KR1019970009736A patent/KR100240143B1/ko not_active IP Right Cessation
- 1997-03-21 CO CO97015478A patent/CO4780017A1/es unknown
- 1997-10-06 TW TW086114594A patent/TW434024B/zh not_active IP Right Cessation
- 1997-10-23 PE PE1997000944A patent/PE799A1/es not_active Application Discontinuation
-
1998
- 1998-07-20 US US09/119,031 patent/US6114336A/en not_active Expired - Lifetime
- 1998-08-07 HK HK98109761A patent/HK1008981A1/xx not_active IP Right Cessation
-
2000
- 2000-02-09 US US09/500,540 patent/US6313128B1/en not_active Expired - Lifetime
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PE799A1 (es) | Composicion cosmetica que contiene un antagonista de los receptores del neuropeptido y | |
TW492865B (en) | Composition for enhancing hyaluronic acid productivity and method for preparing same | |
BR9607565A (pt) | Derivados de hidroxilamina úteis para produção de protetores moleculares e sua preparação | |
AU7023987A (en) | Pharmaceutical compositions containing propylene glycol and/or polyethylene glycol and urea as active main components and use thereof | |
US4508707A (en) | Hair tonic composition | |
MX9305118A (es) | La utilizacion de un ecdisteroide para la preparacion de composiciones cosmeticas o dermatologicas destinadas especialmente para reforzar la funcion de barrera hidrica de la piel, o para la preparacion de un medio de cultivo de las celulas de la piel | |
ES2167808T3 (es) | Preparado cosmetico para la limpieza y el cuidado de la piel a base de extractos de plantas y algas. | |
DE69332350T2 (de) | Verwendung von Lycopen zur Verminderung der Zellaktivität, insbesondere von Krebszellen, sowie entsprechende pharmazeutische Zubereitungen | |
ES2181501T3 (es) | Composicion cosmetica. | |
ATE166532T1 (de) | Anatomisches und biologisches konservierungsmittel und verbesserte einbalsamierungszusammensetzung und -verfahren | |
ATE67671T1 (de) | Praeparat mit wirkung gegen akne sowie verwendung von wirkstoffextrakt des queckenweizens. | |
ES2092868T3 (es) | Utilizacion de derivados de la 4-tiorresorcina en unas composiciones cosmeticas o dermofarmaceuticas de accion despigmentante. | |
AR012546A1 (es) | Utilizacion de al menos un compuesto seleccionado entre el grupo que comprende los sogaoles y los gingeroles para la preparacion de una composiciondesodorante, sogaol, extracto bruto y extracto purificado que contiene el sogaol y la composicion desodorante obtenida. | |
ES2168845T3 (es) | Composicion cosmetica que contiene un componente activo capaz de estimular "in vivo" la produccion de interleuquina 6 (il-6) por los queratinocitos humanos. | |
ES2186914T3 (es) | Utilizacion cosmetica, dermatologica y farmaceutica de un extracto de terminalia catappa. | |
ES2163449T3 (es) | Preparado oxigenado funcional que contiene fosfolipidos y fluorocarbono. | |
KR20160013385A (ko) | 잘피 식물 세포 배양 추출물을 함유한 항염 및 항노화 효과를 지닌 피부 외용제 조성물 및 그 제조방법 | |
KR102278167B1 (ko) | 지질산화 방지, 자외선에 의한 손상 피부 개선 및 피부 진정 효과가 우수한 화장료 조성물 | |
SE9604193D0 (sv) | Therapeutic and cosmetic compositions, their use and method for the preparation thereof | |
KR101805395B1 (ko) | 피부 보습용 화장료 조성물 | |
KR101933599B1 (ko) | 바이텍스 추출물을 이용한 모기 기피제. | |
CN1253495A (zh) | 用于脱除皮肤或其表面生长物的色素的酚衍生物和鸢尾科植物萃取物的组合和包括这种组合的组合物 | |
KR20090052096A (ko) | 이끼 추출물 또는 그 유효 성분인 뎁시돈 또는 뎁시돈유도체를 함유하는 항노화 피부 외용제 조성물 | |
JP2001348337A (ja) | 紫外線からの皮膚防御剤 | |
KR100922199B1 (ko) | 피부 노화를 억제하는 화장료 조성물 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC | Refusal |